Hikma Pharmaceuticals has signed a 50:50 joint venture agreement with MIDROC Pharmaceuticals, a member of Sheikh Mohammed Hussein Al Amoudi's MIDROC Group, to establish a presence in the Ethiopian ...
London-listed Hikma said the joint venture, HikmaCure, would create an Ethiopian operating company, build a local manufacturing facility and would begin marketing and distributing pharmaceutical ...
Hikma Pharmaceuticals USA will invest $1 billion by 2030 to further expand its U.S. manufacturing and R&D capabilities. This new phase of investment -- America Leans on Hikma: Quality Medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results